Antimicrobial Agents and Chemotherapy, April 2001, p. 1249-1253, Vol. 45, No. 4
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1249-1253.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In70 of Plasmid pAX22, a
blaVIM-1-Containing Integron Carrying a New
Aminoglycoside Phosphotransferase Gene Cassette
Maria Letizia
Riccio,1
Lucia
Pallecchi,1
Roberta
Fontana,2 and
Gian
Maria
Rossolini1,*
Dipartimento di Biologia Molecolare, Sezione
di Microbiologia, Università di Siena, I-53100
Siena,1 and Dipartimento di
Patologia, Sezione di Microbiologia, Università di Verona,
I-37134 Verona,2 Italy
Received 7 August 2000/Returned for modification 18 December
2000/Accepted 26 January 2001
 |
ABSTRACT |
An Achromobacter xylosoxydans strain showing
broad-spectrum resistance to
-lactams (including
carbapenems) and aminoglycosides was isolated at the
University Hospital of Verona (Verona, Italy). This strain was found to
produce metallo-
-lactamase activity and to harbor a 30-kb
nonconjugative plasmid, named pAX22, carrying a
blaVIM-1 determinant inserted into a class 1 integron. Characterization of this integron, named In70, revealed an
original array of four gene cassettes containing, respectively, the
blaVIM-1 gene and three different
aminoglycoside resistance determinants, including an aacA4
allele, a new aph-like gene named aphA15, and
an aadA1 allele. The aphA15 gene is the first
example of an aph-like gene carried on a mobile gene
cassette, and its product exhibits close similarity to the APH(3')-IIa
aminoglycoside phosphotransferase encoded by Tn5 (36%
amino acid identity) and to an APH(3')-IIb enzyme from
Pseudomonas aeruginosa (38% amino acid identity). Expression of the cloned aphA15 gene in Escherichia
coli reduced the susceptibility to kanamycin and neomycin as well
as (slightly) to amikacin, netilmicin, and streptomycin.
Characterization of the 5' and 3' conserved segments of In70 and of
their flanking regions showed that In70 belongs to the group of class 1 integrons associated with defective transposon derivatives originating
from Tn402-like elements. The structure of the 3'
conserved segment indicates the closest ancestry with members of
the In0-In2 lineage. In70, with its array of cassette-borne resistance
genes, can mediate broad-spectrum resistance to most
-lactams and aminoglycosides.
 |
INTRODUCTION |
VIM-1 and VIM-2 are new
metallo-
-lactamases, 90% identical to each other at the sequence
level, that have recently been identified in
carbapenem-resistant Pseudomonas aeruginosa
nosocomial isolates from the Mediterranean area (12, 17, 21,
27). These enzymes exhibit a very broad substrate specificity
(including carbapenems and most other
-lactams) and were
found to be encoded by determinants carried on mobile gene cassettes
inserted into integrons (12, 17). Integrons and gene
cassettes are elements that participate in a powerful site-specific
recombination system, operating in procaryotic genomes, that plays a
major role in spreading of antibiotic resistance genes in the clinical
setting (see references 8 and 19 for reviews). For the
above reasons, the blaVIM-1 and blaVIM-2 genes could become relevant resistance
determinants in the clinical setting.
The blaVIM-1 gene was originally cloned from a
P. aeruginosa strain that was isolated at the University
Hospital of Verona (Verona, Italy), having caused an outbreak in the
Intensive Care Unit of that hospital (14). In that strain,
the blaVIM-1 gene was found to be part of a gene
cassette carried on a class 1 integron that was only partially
characterized (12) and was located on the bacterial chromosome.
Here we report on the finding of a plasmid-borne
blaVIM-1 determinant in an Achromobacter
xylosoxydans isolate from the same hospital and on the
characterization of the blaVIM-1-containing integron carried by that plasmid.
 |
MATERIALS AND METHODS |
Bacterial strains and genetic vectors.
A.
xylosoxydans subsp. denitrificans AX-22 was isolated in
1998 from a urine specimen of an inpatient at the University Hospital of Verona, Verona, Italy, and identified according to standard procedures (23). Escherichia coli DH5
(GIBCO-BRL, Gaithersburg, Md.) was used as the host for natural and
recombinant plasmids. E. coli MKD-135 (argH rpoB18
rpoB19 recA rpsL) (kindly provided by G. Kholodii, Institute for
Molecular Genetics, Russian Academy of Sciences, Moscow, Russia) and
P. aeruginosa 10145/3 (an rpoB his derivative of
strain ATCC 10145T) were used as recipients in conjugation
experiments. Bacteria were always grown aerobically at 37°C unless
otherwise specified. The plasmids pBC-SK and pBluescript KS
(Stratagene, Inc., La Jolla, Calif.) were used as cloning vectors.
In vitro susceptibility testing.
Antibiotics were from
commercial sources. MICs were determined by a macrodilution broth
method (15), using Mueller-Hinton (MH) broth (Difco
Laboratories, Detroit, Mich.) and a bacterial inoculum of 5 × 105 CFU per tube. Results were recorded after incubation
for 18 h at 37°C and interpreted according to the guidelines of
the National Committee for Clinical Laboratory Standards
(16).
-lactamase assays.
Carbapenemase activity in crude cell
extracts was assayed spectrophotometrically as described previously
(12), using 150 µM imipenem as the substrate. One unit
was defined as the amount of activity hydrolyzing 1 nmol of substrate
per min under the assay conditions. Inhibition of the
carbapenemase activity by EDTA was assayed as described
previously (12). Protein concentration in solution was
assayed by the method of Bradford with a commercial kit (Protein Assay;
Bio-Rad, Richmond, Calif.), with bovine serum albumin used as a
standard. Analytical isoelectric focusing for detection of
-lactamases was performed as described previously (12).
DNA analysis methodology.
Basic procedures for DNA
extraction, analysis, and manipulation were performed as described by
Sambrook et al. (22). Hybridization experiments were
carried out using nitrocellulose filters (Schleicher & Schuell, Dassel,
Germany) and a probe labeled with 32P by the random priming
technique (22). The probe was a PCR-generated amplicon
comprising the entire blaVIM-1 open reading
frame (ORF) (12). P. aeruginosa VR-143/97
(12) and P. aeruginosa ATCC27853 were
included as positive and negative hybridization controls, respectively,
in colony blot hybridization. Conjugation experiments were performed on
MH agar plates. The initial donor/recipient ratio was 0.1. Mating
plates were incubated at 30°C for 14 h. E. coli
transconjugants were selected on MH agar containing kanamycin (25 µg/ml) plus rifampin (400 µg/ml). P. aeruginosa
transconjugants were selected on MH agar containing tobramycin (16 µg/ml) plus rifampin (400 µg/ml). The detection sensitivity of the
assay was
1 × 10
8 transconjugants/recipient.
Electroporation of E. coli was performed with a Gene-Pulser
apparatus (Bio-Rad) according to the manufacturer's instructions. DNA
sequences were determined on both strands of plasmid templates as
described previously (12). Similarity searches against
sequence databases were performed using an updated version of the BLAST
program at the National Center for Biotechnology Information server
(http://www.ncbi.nlm.nih.gov/). Computer analysis of the
sequence data and multiple-sequence alignment were performed using the
Wisconsin Package (version 8.1; Genetics Computer Group Inc., Madison,
Wis.) and the Clustal W program at the server of the Italian European
Molecular Biology Laboratory Node of Bari (area.ba.cnr.it).
Nucleotide sequence accession numbers.
The nucleotide
sequences reported in this paper have been submitted to the EMBL,
GenBank, and DDBJ sequence databases and assigned the accession numbers
AJ278514 and AJ278515.
 |
RESULTS AND DISCUSSION |
Identification of A. xylosoxydans clinical isolate
producing a plasmid-encoded VIM-like metallo-
-lactamase.
A. xylosoxydans AX22 exhibited broad-spectrum resistance to
-lactams and aminoglycosides (Table
1). The
-lactam resistance pattern
(including piperacillin, ceftazidime, and carbapenem
resistance) was unusual for this species (5, 25), and the
high-level carbapenem resistance suggested the production
of an acquired carbapenemase. In fact,
carbapenemase activity was detected in a crude extract of
AX22 (specific activity, 184 ± 12 U/mg of protein), and this
activity was reduced (>80%) after incubation of the crude extract
with 2 mM EDTA, suggesting the presence of a metallo-
-lactamase determinant.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
MICs of various antimicrobial agents for A. xylosoxydans AX22, E. coli DH5 (pAX22), and E. coli DH5 (pMLR-aph70)a
|
|
A colony blot hybridization showed that DNA from AX22 was recognized by
a blaVIM-1 probe (data not shown). Agarose gel
electrophoresis of the total DNA extracted from AX22 revealed the
presence of plasmid DNA which was recognized by the
blaVIM-1 probe in a Southern blot hybridization
(Fig. 1). The
blaVIM-containing plasmid, named pAX22, was
purified and estimated to be approximately 30 kb in size, based on
restriction analysis with various enzymes (Fig. 1). Electroporation of
E. coli DH5
with the purified plasmid preparation yielded
ampicillin-resistant transformants which contained a plasmid
apparently identical to pAX22 (data not shown). DH5
(pAX22) produced carbapenemase activity (specific activity of crude
extract, 202 ± 14 U/mg of protein) and, compared to DH5
,
exhibited a decreased susceptibility to several
-lactams (Table 1).
An isoelectric focusing analysis of a crude extract of
DH5
(pAX22) revealed the presence of a single band of
-lactamase
activity with an isoelectric pH of 5.1 (data not shown), suggesting
that the VIM-like enzyme was the only
-lactamase encoded by
pAX22. In fact, the pattern of
-lactam susceptibility shown by
DH5
(pAX22) was consistent with that previously observed for the same
E. coli host carrying a cloned copy of the
blaVIM-1 gene on a multicopy plasmid vector (12).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Results of agarose gel electrophoresis of genomic
DNA extracted from A. xylosoxydans AX22 are shown at left,
and results of Southern blot hybridization with the
blaVIM-1 probe are shown at right. AX, AX22. (B)
Results of agarose gel electrophoresis of the plasmid DNA preparation
from AX22, either undigested or digested with various enzymes are shown
at left, and results of Southern blot hybridization with the
blaVIM-1 probe are shown at right. U,
undigested; B, BamHI; RI, EcoRI; H,
HindIII; S, SalI. DNA size standards are
reported in kilobase pairs on the sides.
|
|
The potential for conjugational transfer of pAX22 was examined in
diparental matings using either E. coli MKD-135 or P. aeruginosa 10145/3 as the recipient, but in neither case was
conjugational transfer detected. A similar behavior was also observed
with other medium-sized plasmids containing integrons carrying
cassette-borne metallo-
-lactamase genes (11, 17). It
would be interesting to further investigate the biology of these
plasmids and their potential role in the dissemination of resistance determinants.
Structure of blaVIM-containing integron
carried by plasmid pAX22.
The 8.6-kb EcoRI fragment of
pAX22 containing the blaVIM determinant (Fig. 1)
was subcloned into plasmid pBC-SK to obtain the recombinant plasmid
pLUP-86R (Fig. 2). Restriction mapping and partial sequence analysis of this fragment revealed that the blaVIM determinant was inserted into a class 1 integron which carries an original array of four gene cassettes and was
named In70 (Fig. 2).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Physical map of the 8.6-kb EcoRI insert of
plasmid pLUP-86R. The thick line represents the DNA insert; the thin
lines represent vector sequences. Abbreviations: S, SalI;
RI, EcoRI; B, BamHI; Bg, BglII; C,
ClaI; K, KpnI; N, NcoI; P,
PstI; Sa, SacII; X, XhoI. The
horizontal dotted lines above the map indicate the sequenced regions.
The structure of In70 and the locations of the various integron
components are shown below the map. ORFs are indicated by arrows
(truncated when not complete), the 59-be's of the gene cassettes are
indicated by ovals, and the cassette boundaries are indicated by
vertical bars. The 3'-CS has been sequenced only at its junctions,
while the structure of the internal region has been deduced by
comparison of the restriction map with that of the 3'-CS of other
integrons (9).
|
|
The 5' conserved segment (5'-CS) of In70 contains an intI1
allele typical of class 1 integrons (19) and is identical
to that of In0 (2) except for a single G
T transversion
in the
35 hexamer of the P1 promoter (formerly Pant).
Therefore, the configuration of the P1 promoter of In70 is hybrid, with
a TTGACA
35 hexamer typical of the strong P1 promoter and a
TAAGCT
10 hexamer typical of the weak P1 promoter (13),
and is identical to that of the promoter previously found in the
integron from plasmid pBWH301 (4) but different from the
configurations of the promoters found in most other integrons
(reference 13 and references therein, as well as results
of a BLAST search on updated sequence databases). Compared to the
blaVIM-1-containing integron cloned from
P. aeruginosa VR-143/97 (12), the 5'-CS of In70 exhibits the same G
T transversion in the
35 hexamer that
differentiates the P1 promoter of In70 from that of In0 (see above), as
well as a G
C transversion in the region between the
35 and
10
hexamers of the same promoter. A similar finding may indicate cassette exchange rather than integron transfer in the dissemination process of
the blaVIM-1 cassette.
At the left-hand end, the 5'-CS of In70 is bounded by a 25-bp IRi
sequence identical to that associated with other integrons of the same
family (9, 18). The nucleotide sequence flanking IRi was
found to be identical to that flanking IRi of In5, of In18, and of In31
but different from that flanking the IRi of other integrons (Fig.
3A).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Comparison of the IRi (boldfaced) and flanking
region of In70 with those of other integrons of the same family.
Identical flanking sequences are underlined. The sequences of In1, In2,
In3, In4, and In5 (9); of In13, In16, and In18
(18); and of In31 (11) have all been reported
previously. (B) Nucleotide sequence at the junction between the
3'-CS (boldfaced) of In70 and the truncated tni module,
and comparison with the corresponding regions of In0 and In2
(3). The sites of insertion of IS1326 in In0
and in In2 and that of IS1353 in In2 are indicated.
|
|
The 3' conserved segment (3'-CS) of In70 closely resembles that of In0
and In2 (3) but directly merges with a truncated tni module typical of Tn402-like elements, with
no insertion sequences present at the 3'-CS-tniB
junction
(Fig. 2). Compared to In0 and In2 (3), the
3'-CS-tniB
junction of In70 exhibits a small deletion,
apparently involving both sides (Fig. 3B), which could have been
generated following an imprecise excision of IS1326. For
this reason, the truncated tniB allele present in In70 was named tniB
3.
Altogether, these findings indicate that In70 is another member of the
group of class 1 integrons associated with defective transposon
derivatives originating from Tn402-like elements. Among them, In70 apparently shares the closest ancestry with members of the
In0-In2 lineage (2, 3). However, the finding of an IRi-flanking region which is different from that of either In0 or In2
but identical to those of integrons of the In5-In31 lineage (11) raises the question of the mobility of the defective
transposon carrying the integron.
Gene cassettes in In70.
In70 contains four gene
cassettes, each including a resistance gene. The first cassette carries
a blaVIM-1 determinant (Fig. 2) and is identical
to the blaVIM-1 cassette from P. aeruginosa VR-143/97, the VIM-1 index strain previously isolated
in the same hospital (12). This finding suggests a
common origin for the two determinants, although the original source
remains unknown. It also indicates that
blaVIM-1, similar to
blaVIM-2 (17), can even be found on plasmids.
The second cassette of In70 contains an aacA4 allele (Fig.
2) encoding an AAC(6')-II aminoglycoside acetyltransferase
identical to that encoded by the aacA4 allele from plasmid
pIP1855 of Pseudomonas fluorescens BM2687 (10).
The third cassette of In70 is original and contains a 795-bp ORF
encoding a protein which exhibits the closest sequence
similarities with an APH(3')-IIb aminoglycoside
phosphotransferase from P. aeruginosa (7)
(38% identity) and with the APH(3')-IIa enzyme encoded by
Tn5 (1) (36% identity). The similarity to the
above proteins is evident over the entire sequence and includes the three highly conserved motifs and the invariant or highly conserved residues typical of the APH enzymes (24) (Fig.
4). The gene was named aphA15.
To analyze whether the aphA15 product was functional in
conferring aminoglycoside resistance, a 1-kb
KpnI-SacII fragment of In70 including the gene
(Fig. 2) was subcloned into the plasmid vector pBluescript KS to obtain
recombinant plasmid pMLR-aph70, in which the aphA15
determinant was located downstream of the Plac promoter
flanking the vector polylinker. E. coli
DH5
(pMLR-aph70) showed a significant reduction of kanamycin and
neomycin susceptibility, while the MICs of other
aminoglycosides, including gentamicin, tobramycin, netilmicin,
amikacin, streptomycin, and spectinomycin, were apparently
unaffected or only slightly increased (Table 1), revealing a pattern
consistent with that of APH(3') enzymes (24). The
59-base element (59-be [also named attC]) of the
aphA15 cassette of In70 was found to be nearly identical to
that of the aacC1 cassette inserted in In4 of
Tn1696 (Fig. 5A). A similar
situation of gene cassettes containing different resistance
determinants but closely related 59-be's has also been reported in
other cases (20) and supports the view that gene cassettes
can be assembled from pools of different resistance genes and
59-be's and/or that 59-be's can be shuffled between different
cassettes. It should be noted that association with gene cassettes has
been typically reported for aac and aad but not
for aph aminoglycoside resistance determinants (7, 19,
24). Identification of this new cassette demonstrated that also
aph-like determinants can be cassette-borne and can exploit
the potential of the integron-mediated recombination system for
dissemination.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 4.
Amino acid sequence comparison among the putative
APH(3') enzyme encoded by the third cassette of In70 [APH(3')-In70]
and its closest relatives, the APH(3')-IIa enzyme encoded by
Tn5 [APH(3')-IIa] (1) and the APH(3')-IIb
enzyme from P. aeruginosa SCH84043005 [APH(3')-IIb]
(7). Identical residues are each indicated by an asterisk;
conservative amino acid substitutions are each indicated by a dot. The
three highly conserved motifs that are known to be involved in
catalytic activity of the APH enzymes are overlined, and the invariant
or highly conserved residues typical of these enzymes (24)
are shaded.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 5.
(A) Comparison of the 59-be of the aphA15
cassette of In70 (aphA15) with that of the aacC1
cassette of In4 from Tn1696 (19). Identical
residues are indicated by vertical bars. (B) Nucleotide sequence at the
junction between the aadA1 cassette and the the 3'-CS
internal boundary of In70, showing the structure of the deleted 59-be
of the aadA1 cassette. The termination codon of the
aadA1 coding sequence is capitalized; the sequence of the
3'-CS is italicized, and the conserved recombination core site located
at the 3'-CS internal boundary is boxed. The 1L internal core site of
the 59-be (26) is overlined by an arrow. The deleted
region, in comparison with the 59-be of the aadA1 cassette
of In2 (19), is indicated below the sequence and the 2L
and 2R internal core sites (26) are underlined by
arrows.
|
|
The fourth cassette of In70 contains an aadA1 allele
encoding an AAD(3") aminoglycoside adenylyl transferase
(24) and a partially deleted 59-be (Fig. 5B). Compared to
the 59-be of the aadA1 cassette of In2, the deletion
involves a 40-bp region precisely located between the 1L (retained) and
2R (deleted) core sites of the 59-be (26) (Fig. 5B),
suggesting that it was likely generated by an unusual
integrase-mediated recombination event between 1L and 2R.
Concluding remarks.
In70 is a new class 1 integron that can
mediate broad spectrum
-lactam and aminoglycoside resistance owing
to the simultaneous carriage of a gene cassette encoding the VIM-1
metallo-
-lactamase, which can degrade virtually all
-lactams
except monobactams (6), and of three gene cassettes
encoding three different modifying enzymes whose combined
substrate spectrum includes most aminoglycosides. This fact, together
with the plasmid-borne nature, could render In70 a powerful
vehicle for spreading multidrug resistance among gram-negative
nosocomial pathogens. We are currently analyzing the structures of the
blaVIM-containing integrons present on the chromosome of P. aeruginosa VR-143/97 (12) and
of other VIM-1-producing P. aeruginosa isolates
(21) to compare their structures with that of In70.
 |
ACKNOWLEDGMENTS |
This work was supported by the European research network on
metallo-
-lactamases within the TMR program (contract no.
FMRX-CT98-0232) and by grant no. 9906404271 from MURST (PRIN99).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dipartimento di
Biologia Molecolare, Sezione di Microbiologia, Università di
Siena, Via Laterina, 8, 53100 Siena, Italy. Phone: 39 0577 233327. Fax: 39 0577 233325. E-mail:
rossolini{at}unisi.it.
 |
REFERENCES |
| 1.
|
Beck, E.,
G. Ludwig,
E. A. Auerswald,
B. Reiss, and H. Schaller.
1982.
Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5.
Gene
19:327-336[CrossRef][Medline].
|
| 2.
|
Bissonnette, L., and P. H. Roy.
1992.
Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria.
J. Bacteriol.
174:1248-1257[Abstract/Free Full Text].
|
| 3.
|
Brown, H. J.,
H. W. Stokes, and R. M. Hall.
1996.
The integrons In0, In2, and In5 are defective transposon derivatives.
J. Bacteriol.
178:4429-4437[Abstract/Free Full Text].
|
| 4.
|
Bunny, K. L.,
R. M. Hall, and H. W. Stokes.
1995.
New mobile gene cassettes containing an aminoglycoside resistance gene, aacA7, and a chloramphenicol resistance gene, catB3, in an integron in pBWH301.
Antimicrob. Agents Chemother.
39:686-693[Abstract].
|
| 5.
|
Fass, R. J.,
J. Barnishan,
M. C. Solomon, and L. W. Ayers.
1996.
In vitro activities of quinolones, -lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.
Antimicrob. Agents Chemother.
40:1412-1418[Abstract].
|
| 6.
|
Franceschini, N.,
B. Caravelli,
J.-D. Docquier,
M. Galleni,
J.-M. Frére,
G. Amicosante, and G. M. Rossolini.
2000.
Purification and biochemical characterization of the VIM-1 metallo- -lactamase.
Antimicrob. Agents Chemother.
44:3003-3007[Abstract/Free Full Text].
|
| 7.
|
Hächler, H.,
P. Santanam, and F. H. Kayser.
1996.
Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph(3')-IIb, in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
40:1254-1256[Abstract].
|
| 8.
|
Hall, R. M., and C. M. Collis.
1995.
Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination.
Mol. Microbiol.
15:593-600[CrossRef][Medline].
|
| 9.
|
Hall, R. M.,
H. J. Brown,
D. E. Brookes, and H. W. Stokes.
1994.
Integrons found in different locations have identical 5' ends but variable 3' ends.
J. Bacteriol.
176:6286-6294[Abstract/Free Full Text].
|
| 10.
|
Lambert, T.,
M.-C. Ploy, and P. Courvalin.
1994.
A spontaneous mutation in the aac(6')-Ib gene results in altered substrate specificity of aminoglycoside 6'-N-acetyltransferase of a Pseudomonas fluorescens strain.
FEMS Microbiol. Lett.
115:297-304[Medline].
|
| 11.
|
Laraki, N.,
M. Galleni,
I. Thamm,
M. L. Riccio,
G. Amicosante,
J.-M. Frère, and G. M. Rossolini.
1999.
Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes.
Antimicrob. Agents Chemother.
43:890-901[Abstract/Free Full Text].
|
| 12.
|
Lauretti, L.,
M. L. Riccio,
A. Mazzariol,
G. Cornaglia,
G. Amicosante,
R. Fontana, and G. M. Rossolini.
1999.
Cloning and characterization of blaVIM, a new integron-borne metallo- -lactamase gene from a Pseudomonas aeruginosa clinical isolate.
Antimicrob. Agents Chemother.
43:1584-1590[Abstract/Free Full Text].
|
| 13.
|
Lévesque, C.,
S. Brassard,
J. Lapointe, and P. H. Roy.
1994.
Diversity and relative strength of tandem promoters for the antibiotic resistance genes of several integrons.
Gene
142:49-54[CrossRef][Medline].
|
| 14.
|
Mazzariol, A.,
G. Cornaglia,
P. Piccoli,
L. Lauretti,
M. L. Riccio,
G. M. Rossolini, and R. Fontana.
1999.
Carbapenem-hydrolyzing -lactamases in Pseudomonas aeruginosa.
Eur. J. Clin. Microbiol. Infect. Dis.
18:455-456[CrossRef][Medline].
|
| 15.
|
National Committee for Clinical Laboratory Standards.
1997.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS document M7-A4.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 16.
|
National Committee for Clinical Laboratory Standards.
1999.
Performance standards for antimicrobial susceptibility testing. Supplement M100-S9.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 17.
|
Poirel, L.,
T. Naas,
D. Nicholas,
L. Collet,
S. Bellais,
J.-D. Cavallo, and P. Nordmann.
2000.
Characterization of VIM-2, a carbapenem-hydrolyzing metallo- -lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
Antimicrob. Agents Chemother.
44:891-897[Abstract/Free Full Text].
|
| 18.
|
Rådström, P.,
O. Sköld,
G. Swedberg,
J. Flensburg,
P. H. Roy, and L. Sundström.
1994.
Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements.
J. Bacteriol.
176:3257-3268[Abstract/Free Full Text].
|
| 19.
|
Recchia, G. D., and R. M. Hall.
1995.
Gene cassettes: a new class of mobile element.
Microbiology
141:3015-3027[Medline].
|
| 20.
|
Recchia, G. D., and R. M. Hall.
1997.
Origins of the mobile gene cassettes found in integrons.
Trends Microbiol.
5:389-394[CrossRef][Medline].
|
| 21.
|
Rossolini, G. M.,
M. L. Riccio,
G. Cornaglia,
L. Pagani,
C. Lagatolla,
L. Selan, and R. Fontana.
2000.
Carbapenem-resistant Pseudomonas aeruginosa with acquired blaVIM metallo- -lactamase determinants, Italy.
Emerg. Infect. Dis.
6:312-313[Medline].
|
| 22.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 23.
|
Schreckenberger, P. C., and A. von Graevenitz.
1999.
Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods, p. 539-560.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
|
| 24.
|
Shaw, K. J.,
P. N. Rather,
R. S. Hare, and G. H. Miller.
1993.
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.
Microbiol. Rev.
57:138-163[Abstract/Free Full Text].
|
| 25.
|
Spangler, S. K.,
M. A. Visalli,
M. R. Jacobs, and P. C. Appelbaum.
1996.
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulphamethoxazole, and imipenem.
Antimicrob. Agents Chemother.
40:772-775[Abstract].
|
| 26.
|
Stokes, H. W.,
D. B. O'Gorman,
G. D. Recchia,
M. Parsekhian, and R. M. Hall.
1997.
Structure and function of 59-base element recombination sites associated with mobile gene cassettes.
Mol. Microbiol.
26:731-745[CrossRef][Medline].
|
| 27.
|
Tsakris, A.,
S. Pournaras,
N. Woodford,
M.-F. I. Palepou,
G. S. Babini,
J. Douboyas, and D. M. Livermore.
2000.
Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.
J. Clin. Microbiol.
38:1290-1292[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, April 2001, p. 1249-1253, Vol. 45, No. 4
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1249-1253.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.